NephroGenex raises $37.2 million in IPO

Kidney disease company NephroGenex Inc. (NASDAQ:NRX) raised $37.2 million in an IPO

Read the full 128 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE